Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$39.13 - $47.24 $1,526 - $1,842
-39 Reduced 0.71%
5,420 $219,000
Q2 2023

Aug 11, 2023

SELL
$43.93 - $46.76 $18,626 - $19,826
-424 Reduced 7.21%
5,459 $245,000
Q1 2023

May 12, 2023

SELL
$45.29 - $50.76 $51,268 - $57,460
-1,132 Reduced 16.14%
5,883 $270,000
Q4 2022

Feb 13, 2023

SELL
$41.91 - $50.48 $6,915 - $8,329
-165 Reduced 2.3%
7,015 $349,000
Q3 2022

Nov 10, 2022

SELL
$40.9 - $50.42 $43,885 - $54,100
-1,073 Reduced 13.0%
7,180 $296,000
Q2 2022

Aug 12, 2022

BUY
$42.98 - $49.77 $65,028 - $75,302
1,513 Added 22.45%
8,253 $390,000
Q1 2022

May 13, 2022

SELL
$42.23 - $54.3 $90,963 - $116,962
-2,154 Reduced 24.22%
6,740 $330,000
Q4 2021

Feb 11, 2022

SELL
$50.62 - $56.47 $107,972 - $120,450
-2,133 Reduced 19.34%
8,894 $494,000
Q3 2021

Nov 12, 2021

SELL
$46.55 - $56.83 $134,855 - $164,636
-2,897 Reduced 20.81%
11,027 $570,000
Q2 2021

Aug 13, 2021

SELL
$46.28 - $52.75 $69,929 - $79,705
-1,511 Reduced 9.79%
13,924 $674,000
Q1 2021

May 14, 2021

BUY
$46.25 - $56.02 $273,615 - $331,414
5,916 Added 62.15%
15,435 $752,000
Q4 2020

Feb 12, 2021

BUY
$46.09 - $54.74 $438,730 - $521,070
9,519 New
9,519 $503,000
Q2 2020

Aug 13, 2020

SELL
$39.49 - $44.36 $473,050 - $531,388
-11,979 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$33.17 - $41.6 $287,086 - $360,048
-8,655 Reduced 41.95%
11,979 $498,000
Q4 2019

Feb 13, 2020

SELL
$25.41 - $43.1 $46,906 - $79,562
-1,846 Reduced 8.21%
20,634 $697,000
Q3 2019

Nov 13, 2019

BUY
$32.73 - $40.81 $132,425 - $165,117
4,046 Added 21.95%
22,480 $741,000
Q2 2019

Aug 13, 2019

BUY
$35.73 - $41.39 $330,716 - $383,105
9,256 Added 100.85%
18,434 $747,000
Q1 2019

May 14, 2019

BUY
$33.78 - $40.68 $242,979 - $292,611
7,193 Added 362.37%
9,178 $373,000
Q4 2018

Feb 13, 2019

BUY
$32.65 - $37.95 $64,810 - $75,330
1,985 New
1,985 $68,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.5B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Fort, L.P. Portfolio

Follow Fort, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Fort, L.P. with notifications on news.